AS

Alben Sigamani

Active Director Director DIN 08939792
DIN 08939792 First appointment Apr 2021 Primary industry Research & Development
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Apr 2021
Shareholding value •••• Premium profile

About Alben Sigamani

Data last updated:

Alben Sigamani is a Director at Carmel Research Consultancy Private Limited (since 2022), Additional Director at Neomics Research Foundation (since 2023) and Director at First Person Health Solutions India Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Research & Development, Healthcare and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹1.75 Cr; the largest is Carmel Research Consultancy Private Limited at ₹1.45 Cr (FY 2025). Earlier, Alben Sigamani was an Additional Director at Alke Research Private Limited (2021).

DIN 08939792
Primary Designation Director
Industry Research & Development
First Appointment 01 Apr 2021
Oldest Company Age 12 yrs
Largest company Carmel Research Consultancy Private Limited · ₹1.45 Cr (FY 2025)
Combined revenue ₹1.75 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20222022₹1.45 Cr (FY 2025)Active
Neomics Research Foundation U73100AS2014NPL011785
Additional Director31 Oct 20232014₹23.6 Lakh (FY 2022)Active
Director09 Sep 20252022₹5.1 Lakh (FY 2025)Active
Exactitude Medical Foundation U86201KA2024NPL190598
Director08 Jul 20242024₹47,002 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alke Research Private Limited U73100KA2020PTC141945
Additional Director01 Apr 20212020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Carmel Research Consultancy Private Limited
Exactitude Medical Foundation
First Person Health Solutions India Private Limited
Neomics Research Foundation
Premium access

Shareholding and investment profile for Alben Sigamani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alben Sigamani

Alben Sigamani currently holds 4 directorships: Carmel Research Consultancy Private Limited (Director, since 27 Jun 2022, revenue ₹1.45 Cr (FY 2025)); Neomics Research Foundation (Additional Director, since 31 Oct 2023, revenue ₹23.6 Lakh (FY 2022)); First Person Health Solutions India Private Limited (Director, since 09 Sep 2025, revenue ₹5.1 Lakh (FY 2025)); Exactitude Medical Foundation (Director, since 08 Jul 2024, revenue ₹47,002 (FY 2025)).

Alben Sigamani was first appointed on 01 Apr 2021 as Additional Director at Alke Research Private Limited. The most recent appointment on record is 09 Sep 2025 at First Person Health Solutions India Private Limited.

The 4 current companies of Alben Sigamani that report revenue have a combined latest revenue of ₹1.75 Cr: Carmel Research Consultancy Private Limited ₹1.45 Cr (FY 2025); Neomics Research Foundation ₹23.6 Lakh (FY 2022); First Person Health Solutions India Private Limited ₹5.1 Lakh (FY 2025); Exactitude Medical Foundation ₹47,002 (FY 2025).

Alben Sigamani held 1 earlier board appointment: Alke Research Private Limited (Additional Director, 01 Apr 2021 to 09 Dec 2021).

The current boards of Alben Sigamani's companies include Noel Alben (Carmel Research Consultancy Private Limited), Anjali Choudhury (Neomics Research Foundation), Anjali Putra Netraranjn (Neomics Research Foundation), Joel Adams (First Person Health Solutions India Private Limited), Sujata Rakhra (First Person Health Solutions India Private Limited), Ragavendra Ramakrishna Baliga (Exactitude Medical Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available